Back icon Back
NewLimit

NewLimit

Company

NewLimit raises $130 million Series B led by Kleiner Perkins alongside NFDG, Khosla Ventures, Human Capital and others
NewLimit is developing medicines to extend human healthspan through epigenetic reprogramming
We founded NewLimit to develop medicines that add healthy years to each human life. Initially, we thought it would take many years to show progress

https://blog.newlimit.com/p/newlimit-raises-130-million-series

Date

May 6, 2025

Category

biotech

Lead investor

Country Icon Kleiner Perkins

Stage

Series B

Size

$130M

Explore similar Investments to NewLimit

Company
Size
Date
Lead Investor
Press
Chalk

Chalk

Company
$50M
May 28, 2025
Investor Felicis
Source
The General Intelligence Company

The General Intelligence Company

Company
$2.2M
Apr 14, 2025
Investor Acrew Capital
Source
Planned

Planned

Company
$35M
Jul 18, 2024
Investor Drive Capital
Source
The Network

The Network

Company
$2.5M
Aug 6, 2025
Investor HF0
Source
Ekho

Ekho

Company
$17.3M
Jul 8, 2025
Investor Activant Capital
Source
Paraform

Paraform

Company
$20M
Jun 24, 2025
Investor Felicis
Source
Ambrook

Ambrook

Company
$26.1M
Jul 1, 2025
Investor Thrive Capital
Source
webAI

webAI

Company
$24M
Sep 10, 2024
Investor Sequoia
Source
Wordware

Wordware

Company
$30M
Nov 21, 2024
Investor Spark Capital
Source
Statsig

Statsig

Company
$100M
May 6, 2025
Investor ICONIQ Growth
Source
RemoFirst

RemoFirst

Company
$25M
Mar 6, 2024
Investor Octopus Ventures
Source
Vectara

Vectara

Company
$25M
Jul 16, 2024
Investor Race Capital
Source

Startups, venture funds
& everything in between.

Explore verified companies, top VCs, and practical guides built to help you raise, invest, and grow faster.
Made by Omnius. For builders, by builders.
Venture Funds Startups Investments Events Programs Case Studies Interviews & Lectures Reports & Publications